Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors
NCT00047320 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 104
Last updated 2018-02-14
Summary
RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. Giving a chemotherapy drug before surgery may shrink the tumor so that it is no longer present by conventional imaging and tumor markers from serum and cerebrospinal fluid. Radiation therapy uses high-energy x-rays to damage tumor cells. Peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. Combining different types of therapy may kill more tumor cells.
PURPOSE: This Phase II trial is studying how well neoadjuvant chemotherapy with or without surgery and with or without high dose chemotherapy and peripheral stem cell transplantation, can increase response rates prior to radiation therapy and increase progression free and overall surviving patients with newly diagnosed intracranial germ cell tumors.
Conditions
- Brain Tumor
- Central Nervous System Tumors
- Childhood Germ Cell Tumor
Interventions
- DRUG
-
Given IV
- DRUG
-
etoposide
Given IV
- DRUG
-
ifosfamide
Given IV
- DRUG
-
thiotepa
Given IV
- PROCEDURE
-
adjuvant therapy
- PROCEDURE
-
conventional surgery
- PROCEDURE
-
neoadjuvant therapy
- PROCEDURE
-
peripheral blood stem cell transplantation
- RADIATION
-
radiation therapy
craniospinal irradiation
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Children's Oncology Group
lead NETWORK
Principal Investigators
-
Stewart Goldman, MD · Ann & Robert H Lurie Children's Hospital of Chicago
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 3 Years
- Max Age
- 24 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-01-31
- Primary Completion
- 2009-02-28
- Completion
- 2009-02-28
Countries
- United States
- Australia
- Canada
- New Zealand
- Switzerland
Study Locations
More Related Trials
-
Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor
NCT02784054 ·Status: UNKNOWN ·Phase: PHASE2
-
Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor
NCT00085098 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer
NCT00003309 ·Status: COMPLETED ·Phase: PHASE2
-
Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT00390403 ·Status: COMPLETED ·Phase: PHASE1
-
Prospective Trial for the Diagnosis and Treatment of Intracranial Germ Cell Tumors
NCT01424839 ·Status: UNKNOWN ·Phase: PHASE4
-
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
NCT00114140 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Grade II or Grade III Meningioma
NCT00626730 ·Status: UNKNOWN ·Phase: PHASE2
-
Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT00099125 ·Status: COMPLETED ·Phase: PHASE2
-
Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT00053183 ·Status: COMPLETED ·Phase: PHASE1
-
Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme
NCT00002545 ·Status: COMPLETED ·Phase: PHASE3
-
Stereotactic Radiosurgery in Treating Patients With Brain Metastases
NCT00811655 ·Status: TERMINATED ·Phase: PHASE2
-
Stereotactic Radiosurgery in Treating Patients With Brain Tumors
NCT00019578 ·Status: COMPLETED ·Phase: PHASE1
-
Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
NCT01062425 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT00003996 ·Status: COMPLETED ·Phase: PHASE2
-
External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas
NCT01012609 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Escalation Trial of Neoadjuvant Radiosurgery for the Treatment of Metastatic Brain Tumors
NCT03163368 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma
NCT00005637 ·Status: COMPLETED ·Phase: PHASE1
-
Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme
NCT00027612 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas
NCT00033280 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor
NCT00085202 ·Status: COMPLETED ·Phase: PHASE3
-
Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme
NCT00003417 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases
NCT05341349 ·Status: TERMINATED ·Phase: PHASE1
-
Stereotactic Radiosurgery or Whole Brain Radiation Therapy in Treating Patients With Newly Diagnosed Non-melanoma Brain Metastases
NCT01592968 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM
NCT00004146 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy in Treating Patients With Recurrent Malignant Glioma
NCT00002986 ·Status: COMPLETED ·Phase: PHASE1